Stocks move on the big noon DE ABNB AN MRNA

Stocks move on the big noon: DE, ABNB, AN, MRNA

The Deere 8R Autonomous Tractor


Check out the companies making the biggest moves at noon:

Deere shares rose 7.7% after the company reported earnings per share of $6.55 for the fiscal first quarter, beating the $5.57 expected by analysts polled by Refinitiv. The farm equipment maker’s sales came in at $11.4 billion versus an expected $11.28 billion.

related investment news

This week's top performers include Paramount Global and a little-known pharmaceutical stockCNBC Pro

Airbnb — Shares of the vacation rental company fell 5.3%, a day after rising 13.35% on a stronger-than-expected fourth-quarter earnings report. Some Wall Street analysts remained cautious on the stock, citing risks such as competition and slower-than-expected consumer adoption of alternative accommodation.

Albemarle — The specialty chemicals company fell 10.3%, a day after gaining nearly 5%. Albemarle reported adjusted earnings per share and revenue in line with expectations, per StreetAccount after market close on Wednesday.

Bio-Rad Laboratories — Shares rose 5.5% after the company reported net income of $827.7 million in the fourth quarter after reporting a loss in the same period last year. The company’s non-operating margin also increased to 17.4% from 15.7% in the year-ago period. Still, earnings and sales missed Wall Street estimates.

Zebra Technologies – Shares fell 5.3% after the company forecast full-year revenue would fall slightly. CEO Anders Gustafsson said he was taking a “cautious approach” to the outlook based on an uncertain macroeconomic environment. However, Zebra’s fourth-quarter earnings and revenue beat Wall Street estimates.

AutoNation — The automaker’s stock gained 9.4% after the company beat earnings and revenue expectations for the fourth quarter. AutoNation reported adjusted earnings per share of $6.37 versus Refinitiv’s estimate of $5.83. Revenue of $6.7 billion exceeded the expected $6.52 billion.

DraftKings — Shares rose more than 14% after DraftKings released fourth-quarter results that beat expectations. The sports betting company reported a loss of 53 cents a share on revenue of $855 million. Analysts polled by Refinitiv were expecting a loss of 59 cents a share on sales of $800 million.

Moderna — The biotech’s stock fell more than 4% after its influenza vaccine candidate yielded mixed results in clinical trials.

Redfin — Shares fell 7.1% even after Redfin reported better-than-expected fourth-quarter results. The real estate company reported a loss of 57 cents a share on revenue of $480 million. Analysts were forecasting a loss of $1.08 per share on sales of $445 million, according to consensus estimates from Refinitiv. However, year after year the income has been declining.

Roku — Shares of the streaming device maker erased early gains amid broader Wall Street sell-off. The stock first traded higher after Bank of America double-upgraded the stock to buy on underperformance as the Wall Street company said Roku was on track for revenue and margin improvement. Most recently it had fallen by 1.2%.

DoorDash — Shares of the grocery supplier fell 7.2% after DoorDash reported a mixed fourth quarter. DoorDash reported revenue of $1.82 billion for the quarter, up from the $1.77 billion expected by Refinitiv, and provided an upbeat guidance. However, the company’s loss of $1.65 per share was more than double what analysts were expecting.

Biogen — Shares of the biopharmaceutical company rose 1.6% after Japanese drugmaker Eisai said it expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer. Eisai developed the drug with Biogen.

– CNBC’s Jesse Pound Yun Li and Sarah Min contributed coverage.